Company Search:
Advanced Search
Sponsored Links
Renata Limited Company Snapshot
Renata Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Renata Limited with three other pharmaceutical manufacturers in Asia: Yungshin Global Holding Corp of TAIWAN (2020 sales of 8.08 billion Taiwanese Dollars [US$290.40 million] of which 68% was Taiwan District), Nippon Chemiphar Co., Ltd. of JAPAN (31.76 billion Japanese Yen [US$290.25 million] of which 96% was Pharmaceutical Business), and JiangSu WuZhong Pharmaceutical Development Co Ltd which is based in CHINA (1.87 billion Chinese Renmimbi [US$289.48 million] of which 72% was Pharmaceuticals).

Sales Analysis. During the third fiscal quarter of 2021, sales at Renata Limited totalled 6.50 billion Bangladeshi Taka. This is practically unchanged from the previous year, and is only an increase of 0.4% from the 6.48 billion Bangladeshi Taka in sales at the company during the third quarter of 2020. During the first three quarters of 2021, sales totalled 21.04 billion Bangladeshi Taka, which is 10.2% higher than through the first three fiscal quarters of 2020. There appears to be at least some degree of seasonality in the sales at Renata Limited: during 5 of the previous 6 fiscal years, sales were highest during the fourth quarter. The exception to this was during 2020, when the third quarter was the best quarter, accounting for 26% of sales (during that same year, the fourth quarter accounted for 23% of sales). Renata Limited reported sales of 24.67 billion Bangladeshi Taka (US$290.18 million) for the fiscal year ending June of 2020. This represents an increase of 8.2% versus 2019, when the company's sales were 22.81 billion Bangladeshi Taka. Sales at Renata Limited have increased during each of the previous five years (and since 2015, sales have increased a total of 84%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Renata Limited
  Stock Performance Chart for Renata Limited
  Stock Data: Recent Stock Performance:
  Current Price (9/16/2021): 1,445.00
(Figures in Bangladeshi Taka)
1 Week -0.9%   13 Weeks 2.6%  
4 Weeks 11.8%   52 Weeks 33.9%  
Renata Limited Key Data:
  Ticker: RENATA Country: BANGLADESH
  Exchanges: OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 24,674,812,094
(Year Ending Jan 2021).
Employees: 8,151
  Currency: Bangladeshi Taka Market Cap: 140,812,599,870
  Fiscal Yr Ends: June Shares Outstanding: 97,448,166
  Share Type: Ordinary Closely Held Shares: N/A
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.